QIAGEN Announces $500 Million Synthetic Share Repurchase

QIAGEN N.V. has announced plans to return approximately $500 million to shareholders through a synthetic share repurchase. This procedure combines a direct capital repayment with a reverse stock split, effective around January 7, 2026. The decision follows shareholder approval from the Annual General Meeting in June 2025.

This strategy aims to enhance the company's earnings per share by reducing outstanding shares, providing a potentially more efficient alternative to traditional open-market repurchase programs. The process involves increasing the par value of shares, consolidating through a reverse stock split, and then reducing the par value, allowing for direct capital repayment to shareholders.